Literature DB >> 31116959

Natural inhibitors on airway mucin: Molecular insight into the therapeutic potential targeting MUC5AC expression and production.

Md Samsuzzaman1, Md Sahab Uddin2, Muhammad Ajmal Shah3, Bijo Mathew4.   

Abstract

Airway mucin overproduction is the hallmark risk factor of asthma, which is associated with the reduction of lung function. An aberrant mucin expression is responsible for airway obstruction due to its high viscous characteristics. Among the mucins discovered, MUC5AC is the prime mucin of airway epithelia. Nowadays, mucins induced asthma and chronic obstructive pulmonary disease (COPD) are a great concern all over the world. This review focuses on the effects of natural compounds that can be beneficial to explore new drugs to halt MUC5AC secretion and production in airway epithelial, and also their underlying molecular mechanisms based on recent studies. Several researchers are seeking natural sources to identify a new potent MUC5AC inhibitory agent for clinical applications, because of countable limitations of existing synthetic drugs. Currently, flavonoids, glycoside and steroids like natural compounds have acquired great attention due to their anti-inflammatory and mucoregulatory effects. Most importantly, many natural compounds have shown their potential effects as the modulator of mucin expression, secretion, and production. Therefore, targeting airway MUC5AC expression and production represents an auspicious area of research for the development of drugs against various respiratory diseases.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Airway obstruction; Asthma; Chronic obstructive pulmonary disease; MUC5AC; Mucin; Natural compounds

Mesh:

Substances:

Year:  2019        PMID: 31116959     DOI: 10.1016/j.lfs.2019.05.041

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  The genetic architecture of pneumonia susceptibility implicates mucin biology and a relationship with psychiatric illness.

Authors:  William R Reay; Michael P Geaghan; Murray J Cairns
Journal:  Nat Commun       Date:  2022-06-29       Impact factor: 17.694

2.  Reineckia carnea Alleviates the Production of Inflammatory Cytokines and MUC5AC in Rats with Chronic Obstructive Pulmonary Disease.

Authors:  Wei Liu; Jiang Li; Tongyao Li; Youliang Xie; Caihong Luo
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-16       Impact factor: 2.650

Review 3.  Pathological Mechanism and Targeted Drugs of COPD.

Authors:  Peng Guo; Rui Li; Tie Hua Piao; Chun Lan Wang; Xiao Lu Wu; Hong Yan Cai
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-12

4.  Mucins and Asthma: Are We Headed to the Revolutionary Road?

Authors:  Pierachille Santus; Dejan Radovanovic; Davide Alberto Chiumello
Journal:  J Clin Med       Date:  2019-11-13       Impact factor: 4.241

Review 5.  Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Kamal Niaz; Philippe Jeandet; Christophe Clément; Bijo Mathew; Abdur Rauf; Kannan R R Rengasamy; Eduardo Sobarzo-Sánchez; Ghulam Md Ashraf; Lotfi Aleya
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

Review 6.  Evaluation of Naringenin as a Promising Treatment Option for COPD Based on Literature Review and Network Pharmacology.

Authors:  Zhen Chen; Pan Chen; Hao Wu; Rui Shi; Weiwei Su; Yonggang Wang; Peibo Li
Journal:  Biomolecules       Date:  2020-12-08

7.  Muc5ac Production Inhibited by Decreased lncRNA H19 via PI3K/Akt/NF-kB in Asthma.

Authors:  Xu Chen; Jing Yang; Hailan Shen; Xuemei Zhang; Hong Wang; Guangying Wu; Yuhong Qi; Ling Wang; Wenchun Xu
Journal:  J Asthma Allergy       Date:  2021-08-14

8.  Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment.

Authors:  Junling Pang; Ya Luo; Dong Wei; Zhujie Cao; Xianmei Qi; Meiyue Song; Ying Liu; Zhaoguo Li; Jin Zhang; Baicun Li; Jingyu Chen; Jing Wang; Chen Wang
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

Review 9.  The Potential Role and Regulatory Mechanisms of MUC5AC in Chronic Obstructive Pulmonary Disease.

Authors:  Jingyuan Li; Zuguang Ye
Journal:  Molecules       Date:  2020-09-27       Impact factor: 4.411

10.  Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1).

Authors:  Ling Chen; Jiajia Xu; Meiyu Deng; Yanling Liang; Jinfu Ma; Linghui Zhang; Yijie Wang; Jinping Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.